Commitments and Contingencies Leases Effective March 1, 2019, the Company entered into a lease for its principal executive offices in El Segundo, California, for an initial term of 5 years . The aggregate lease amount for the five-year term is $2.7 million . The future minimum lease payments required under noncancelable lease obligations related to this lease are $2.4 million due through 2023 (approximately $0.5 million annually) and $0.1 million thereafter. Purchase Commitments As of September 28, 2019 , the Company had committed to purchase pea protein inventory totaling $68.0 million , approximately $20 million in the remainder of 2019, $24 million in 2020, and $24 million in 2021. Litigation On May 25, 2017, a former co-manufacturer of the Company filed a complaint against the Company in the Superior Court of the State of California for the County of Los Angeles asserting claims for (1) breach of contract, (2) misappropriation of trade secrets, (3) unfair competition under California Business &amp; Professions Code Section 17200 Et. Seq., (4) money owed and due, (5) declaratory relief, and (6) injunctive relief, each arising out of the Companys decision to terminate an exclusive agreement dated December 2, 2014 between the Company and the former co-manufacturer, pursuant to its terms (see Note 3 ). The Company denies these claims, filed counter-claims on July 27, 2017, alleging (1) breach of contract, (2) unfair competition under California Business &amp; Professions Code Section 17200 Et. Seq., and (3) conversion, and is in the process of litigating this matter. In October 2018, the former co-manufacturer filed an amended complaint that added one of the Companys current contract manufacturers as a defendant, principally for claims arising from the current contract manufacturers alleged use of the former co-manufacturers alleged trade secrets, and for replacing the former co-manufacturer as one of the Companys current co-manufacturers. T he current co-manufacturer filed an answer denying all of the former co-manufacturers claims, and a cross-complaint against Beyond Meat asserting claims of total and partial equitable indemnity, contribution, and repayment. On March 11, 2019, the former co-manufacturer filed a second amended complaint to add claims of fraud and negligent misrepresentation against the Company. On May 30, 2019, the judge denied the Companys motion to dismiss the fraud and negligent misrepresentation claims, allowing the claims to proceed. On June 19, 2019, the Company filed an answer denying the former co-manufacturers claims. A trial date has been set for May 18, 2020. At this time the Company cannot reasonably estimate the potential liability associated with this litigation, but believes the final resolution of this litigation will not have a material adverse effect on its financial position, results of operations, or cash flows. The Company is involved in various legal proceedings, claims, and litigation arising in the ordinary course of business. Based on the facts currently available, the Company does not believe that the disposition of matters that are pending or asserted will have a material effect on its financial statements.